72, 4.43) 0.21 OR, odds ratio; CI, confidence interval; HWE, Hardy-Weinberg equilibrium. * Only female specific cancers were included in the female subgroup. ** All male patients were the patients with prostate cancer Figure 4 Forest plot the HIF-1α 1790 G/A polymorphism and cancer risk [A versue G and (AA+AG) versus GG]. A. Results from the analysis on all available studies.

B. Results from the analysis on breast cancer subgroup. There was significant heterogeneity for allelic frequency comparison and dominant model comparison among the available studies (Table 2). However, the heterogeneity was effectively Cell Cycle inhibitor decreased or removed in the subgroups stratified by gender, ethnicity, and cancer types (Table 2). Publication bias Publication bias was assayed by visual funnel plot inspection and Egger’s test. The funnel plots for T versus C were basically symmetric (Additional file 4A) and Egger’s test did not indicate Selleck PLX3397 asymmetry of the plot [Intercept = 0.5092, 95% CI (-1.5454, 2.5639), P = 0.6065]. The funnel plots for A versus G showed some asymmetry that could suggest the existence of publication bias (Additional file 4B). However, Egger’s test did not show statistical evidence for publication bias [Intercept = -1.82, 95% CI

(-4.1611, 0.5212), P = 0.1108]. Discussion HIF-1 plays a major role in cancer progression and metastasis through activation of various genes that are linked to regulation of angiogenesis, cell survival, and energy metabolism [5, 6]. The HIF-1α gene was previously found to be implicated in the development and progression of cancer [5, 6]. The polymorphisms analyzed in the present Loperamide study consist of C to T and G to A nucleotide substitutions at positions 1772 and 1790 of the exon 12 of the HIF-1α gene [5, 6]. Because a study by Tanimoto et al [6] showed that both of the substitutions displayed an increased transactivation capacity of HIF-1α in vitro, the presence of the variant alleles might be associated with increased cancer susceptibility. However, studies focusing on the association of the HIF-1α gene polymorphism with cancer susceptibility

had controversial conclusions [5, 6, 8–22]. The lack of concordance across many of these studies reflects limitation in the studies, such as small sample sizes, ethnic difference and research methodology. Meta-analysis is a powerful tool for summarizing the results from different studies by producing a single learn more estimate of the major effect with enhanced precision. It can overcome the problem of small sample size and inadequate statistical power of genetic studies of complex traits, and provide more reliable results than a single case-control study [27]. In this meta-analysis, we investigated the association between the HIF-1α 1772 C/T and 1790 G/A polymorphism and cancer risk. The subgroup analyses stratified by cancer types, ethnicity, and gender were also performed.